← Eichor
Study identifier: NCT06590519 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Condition: Type 2 Diabetes Mellitus · Obesity  ·  Sponsor: Universiti Putra Malaysia

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Globally, chronic noncommunicable diseases rank as the leading cause of morbidity and mortality. Diabetes is reaching high epidemic proportions across the globe. The prevalence of diabetes is increasing in Saudi Arabia, with diabetes affecting 14.1% of the population across all age groups and 28% of those over the age of 30. Date seed intake is one of the best-studied patterns. Previous studies findinds showed that the phenolic compounds in date seeds have blood sugar-lowering properties. There is a lack of data on how date seed diets may affect glycaemia control and cardiovascular risk among Saudi Arabian patients with T2DM. Therefore, randomised controlled trials (RCTs) will be conducted to assess the effects of date seeds on glycaemic control and cardiovascular risk among diabetes patients.

This description comes directly from the study's public registry record.

Talk to the study team

Maha Aldaham, Master  ·  +60176652101  ·  maaaldaham8@gmail.com

Zuriati Ibrahim, PhD  ·  +603-97692464  ·  zuriatiib@upm.edu.my

Always discuss trial participation with your own doctor first.

Locations (1)

Dr Zuriati IbrahimSerdang, Selangor, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06590519